SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD./ADR
Clinical trial NCT05445908 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-09-01 → 2026-07-31 3. primary completion date: 2027-09-01 → 2026-07-31 4. enrollment: 175 → 184 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical